AMZN
Amazon.com, Inc.
AMZN's fundamentals are mixed: revenue grew 15%, but free cash flow turned negative. Its PE of 22x looks cheaper than it really is, because one-off gains boosted its recent earnings. Analysts expect strong earnings growth.
BZUN
Baozun Inc.
There isn't enough reported data to score BZUN yet.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
BZUN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Weak |
BZUN's revenue is currently healthy, and its profitability and cash flow are stable, but its balance sheet is weak.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
BZUN PE Valuation
BZUN has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
BZUN Forward outlook
There aren't enough analyst estimates for BZUN to show an outlook.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over BZUN on earnings quality, reporting a profit while its opponent remains loss making.
BZUN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.35 | +$0.12 |
| Q1 2026 | -$0.49 | -$0.04 |
| Q4 2025 | -$0.63 | -$0.17 |
| Q3 2025 | -$0.53 | +$0.05 |
| Q2 2025 | -$0.47 | +$0.21 |
| Q1 2025 | -$0.45 | +$0.21 |
| Q4 2024 | -$0.46 | +$0.23 |
| Q3 2024 | -$0.58 | +$0.63 |
BZUN is still losing money, but far less than before: $0.35 per share over the past year, against $1.51 at its worst in late 2022.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over BZUN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over BZUN on profitability, with a higher operating margin.
BZUN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $410.5M | +7.2% |
| Q1 2026 | $357.3M | +15% |
| Q4 2025 | $476.1M | +5.9% |
| Q3 2025 | $323.6M | +4.8% |
| Q2 2025 | $383.1M | +6.8% |
| Q1 2025 | $309.8M | +4.3% |
| Q4 2024 | $449.4M | +7.7% |
| Q3 2024 | $308.7M | +13% |
BZUN's revenue has grown year over year for 13 quarters in a row: $410M last quarter, up 7.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 1.6% | +2 points |
| Q1 2026 | 0% | +4.1 points |
| Q4 2025 | 6.1% | +3.7 points |
| Q3 2025 | -1.2% | +4.4 points |
| Q2 2025 | -0.4% | +0.4 points |
| Q1 2025 | -4.1% | -1.3 points |
| Q4 2024 | 2.4% | +2.2 points |
| Q3 2024 | -5.6% | +1.9 points |
BZUN's operating margin was 1.6% last quarter, up 2 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
BZUN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $40M | +$40M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
BZUN has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over BZUN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
BZUN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.4% | +823K shares |
| 1 year | +2% | +1.1M shares |
| 3 years | -0.6% | -335K shares |
| 5 years | -21% | -16M shares |
| Available history | -1.2% | -712K shares |
BZUN has 59M diluted shares, up 2% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $1.5M |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BZUN spent $2M buying back its own shares over the past year, after none the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
BZUN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2025 | 141.2x | High |
| Q4 2024 | 12.1x | High |
| Q4 2021 | -6.6x | Net Cash |
| Q3 2021 | 2.6x | Moderate |
| Q2 2021 | -0.5x | Net Cash |
| Q1 2021 | -0.6x | Net Cash |
| Q4 2020 | -1.3x | Net Cash |
| Q3 2020 | -2.2x | Net Cash |
BZUN's net debt is more than 20 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
BZUN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.4 | Neutral |
| Stochastic | 59.0 | Neutral |
BZUN's weekly RSI is 60 (neutral) and its Stochastic is 59 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
BZUN PE vs Consumer Cyclical Sector
| Metric | BZUN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
BZUN has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
BZUN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 3.6% above |
| 20 week MA | $3.02 | 15% above |
| 50 week MA | $2.80 | 24% above |
| 100 week MA | $2.95 | 18% above |
| 200 week MA | $3.22 | 8.1% above |
BZUN has climbed back above all five of its weekly moving averages, and it's now 8.1% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
BZUN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $33.3 | $32.0 | -4% |
| 2021 | $32.0 | $14.0 | -56% |
| 2022 | $14.0 | $5.01 | -64% |
| 2023 | $5.01 | $2.74 | -45% |
| 2024 | $2.74 | $2.90 | +5.8% |
| 2025 | $2.90 | $2.70 | -6.9% |
| 2026 YTD | $2.70 | $3.48 | +29% |
BZUN has the edge over AMZN on returns for 2026, with the stronger performance.